As an expert in the field of healthcare and insurance, I have been closely following the recent proposal introduced by Governor Gavin Newsom to stop covering popular weight-loss drugs Ozempic and Wegovy under Medi-Cal. This decision has sparked a lot of debate and concern among low-income Californians who rely on this program for their health coverage. In this article, I will provide a comprehensive overview of the proposal and its potential impact on patients seeking weight-loss treatment.
Related Articles
Weight Loss with Ozempic vs Wegovy: An Expert's Perspective
Learn about the differences between Ozempic and Wegovy for weight loss, including their effectiveness, side effects, dosage, and cost. Find out which medication may be the best option for you.
The King Kong of Weight Loss Drugs: A Closer Look at Zepbound
Discover the latest FDA-approved weight-loss drug, Zepbound, also known as the “King Kong of weight-loss drugs.” Learn about its active ingredient tirzepatide and how it can help you lose up to 52 pounds in just 16 months.
The Importance of BMI in Determining Eligibility for Weight Loss Medication
Learn about the requirements for weight loss medication and why BMI is a crucial factor in determining eligibility.
The Expert's Guide to Qualifying for Weight Loss Medication
Learn about the qualifications for weight loss medication and how to determine if it is the right option for you.
